questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Lectines
Galectines
Galectine -3
Galectine -3 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Galectine-3
Tests de laboratoire
Galectine-3
Imagerie médicale
Galectine-3
Analyse d'urine
Symptômes
5
Douleur
Maladies inflammatoires
Symptômes cardiaques
Essoufflement
Prévention
5
Prévention
Mode de vie sain
Exercice physique
Galectine-3
Alimentation
Aliments transformés
Traitements
5
Suppléments alimentaires
Régime alimentaire
Maladies cardiovasculaires
Oncologie
Thérapie génique
Galectine-3
Complications
5
Complications cardiovasculaires
Galectine-3
Insuffisance cardiaque
Galectine-3
Maladies neurodégénératives
Galectine-3
Facteurs de risque
5
Stress chronique
Galectine-3
Maladies auto-immunes
Galectine-3
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Galectine -3 : Questions médicales les plus fréquentes",
"headline": "Galectine -3 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Galectine -3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2025-02-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Galectine -3"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Galectines",
"url": "https://questionsmedicales.fr/mesh/D037161",
"about": {
"@type": "MedicalCondition",
"name": "Galectines",
"code": {
"@type": "MedicalCode",
"code": "D037161",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.503.307"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Galectine -3",
"alternateName": "Galectin 3",
"code": {
"@type": "MedicalCode",
"code": "D037502",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Çiğdem Yücel",
"url": "https://questionsmedicales.fr/author/%C3%87i%C4%9Fdem%20Y%C3%BCcel",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, University of Health Science, Ankara City Hospital, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Aybeniz Civan Kahve",
"url": "https://questionsmedicales.fr/author/Aybeniz%20Civan%20Kahve",
"affiliation": {
"@type": "Organization",
"name": "Gazi University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Işık Batuhan Çakmak",
"url": "https://questionsmedicales.fr/author/I%C5%9F%C4%B1k%20Batuhan%20%C3%87akmak",
"affiliation": {
"@type": "Organization",
"name": "Sungurlu State Hospital, Department of Psychiatry, Corum, Turkey."
}
},
{
"@type": "Person",
"name": "Erol Göka",
"url": "https://questionsmedicales.fr/author/Erol%20G%C3%B6ka",
"affiliation": {
"@type": "Organization",
"name": "University of Health Sciences, Ankara City Hospital, Department of Psychiatry, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Massiullah Shafaq-Zadah",
"url": "https://questionsmedicales.fr/author/Massiullah%20Shafaq-Zadah",
"affiliation": {
"@type": "Organization",
"name": "Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Scleroderma and scleroderma-like syndromes.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38887288",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1351675"
}
},
{
"@type": "ScholarlyArticle",
"name": "Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis.",
"datePublished": "2022-06-01",
"url": "https://questionsmedicales.fr/article/35648373",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12016-022-08945-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis.",
"datePublished": "2022-07-31",
"url": "https://questionsmedicales.fr/article/35921989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.autrev.2022.103162"
}
},
{
"@type": "ScholarlyArticle",
"name": "Acute limb ischemia in an adolescent with COVID-19 and systemic scleroderma: a case report.",
"datePublished": "2022-12-28",
"url": "https://questionsmedicales.fr/article/36577976",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12887-022-03761-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Race and Risk of Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/34738330",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acr.24807"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lectines",
"item": "https://questionsmedicales.fr/mesh/D037102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Galectines",
"item": "https://questionsmedicales.fr/mesh/D037161"
},
{
"@type": "ListItem",
"position": 6,
"name": "Galectine -3",
"item": "https://questionsmedicales.fr/mesh/D037502"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Galectine -3 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Galectine -3",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Galectine -3",
"description": "Comment mesurer le taux de galectine-3 ?\nQuels tests sont utilisés pour le diagnostic ?\nLa galectine-3 est-elle un biomarqueur ?\nQuels médecins évaluent la galectine-3 ?\nPeut-on détecter la galectine-3 dans l'urine ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Scleroderma,+Systemic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Galectine -3",
"description": "Quels symptômes sont liés à la galectine-3 ?\nLa galectine-3 cause-t-elle des douleurs ?\nY a-t-il des symptômes cardiaques associés ?\nLa galectine-3 est-elle liée à la fatigue ?\nQuels signes cliniques sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Scleroderma,+Systemic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Galectine -3",
"description": "Comment prévenir l'augmentation de la galectine-3 ?\nL'exercice physique influence-t-il la galectine-3 ?\nY a-t-il des aliments à éviter ?\nLe stress affecte-t-il la galectine-3 ?\nDes suppléments peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Scleroderma,+Systemic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Galectine -3",
"description": "Quels traitements ciblent la galectine-3 ?\nLa galectine-3 peut-elle être traitée par des médicaments ?\nY a-t-il des traitements naturels pour la galectine-3 ?\nLes traitements varient-ils selon la maladie ?\nLa thérapie génique peut-elle cibler la galectine-3 ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Scleroderma,+Systemic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Galectine -3",
"description": "Quelles complications sont liées à la galectine-3 ?\nLa galectine-3 aggrave-t-elle les maladies ?\nY a-t-il des risques de cancer associés ?\nLa galectine-3 influence-t-elle la fibrose ?\nDes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Scleroderma,+Systemic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Galectine -3",
"description": "Quels facteurs augmentent la galectine-3 ?\nLe tabagisme influence-t-il la galectine-3 ?\nL'âge est-il un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nY a-t-il un lien avec les maladies auto-immunes ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Scleroderma,+Systemic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le taux de galectine-3 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de galectine-3 se mesure par un test sanguin spécifique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La galectine-3 est-elle un biomarqueur ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est considérée comme un biomarqueur pour certaines maladies."
}
},
{
"@type": "Question",
"name": "Quels médecins évaluent la galectine-3 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cardiologues et oncologues évaluent souvent la galectine-3."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la galectine-3 dans l'urine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La galectine-3 est principalement mesurée dans le sang, pas dans l'urine."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la galectine-3 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est associée à des symptômes d'inflammation et de fibrose."
}
},
{
"@type": "Question",
"name": "La galectine-3 cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut contribuer à des douleurs liées à des maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cardiaques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'essoufflement peuvent être présents."
}
},
{
"@type": "Question",
"name": "La galectine-3 est-elle liée à la fatigue ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être associée à la fatigue dans des conditions inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'œdème et la dyspnée peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'augmentation de la galectine-3 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, peut aider."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il la galectine-3 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut réduire les niveaux de galectine-3."
}
},
{
"@type": "Question",
"name": "Y a-t-il des aliments à éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments transformés et riches en sucres peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il la galectine-3 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter les niveaux de galectine-3."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les oméga-3, peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent la galectine-3 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de galectine-3 sont en développement pour diverses maladies."
}
},
{
"@type": "Question",
"name": "La galectine-3 peut-elle être traitée par des médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments visent à réduire son activité dans le corps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour la galectine-3 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches diététiques et des suppléments peuvent aider à la réguler."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la maladie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements dépendent de la maladie associée à la galectine-3."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle cibler la galectine-3 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches explorent la thérapie génique pour moduler son expression."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à la galectine-3 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est liée à des complications cardiovasculaires et pulmonaires."
}
},
{
"@type": "Question",
"name": "La galectine-3 aggrave-t-elle les maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aggraver des maladies comme l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de galectine-3 sont associés à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "La galectine-3 influence-t-elle la fibrose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle joue un rôle clé dans le développement de la fibrose tissulaire."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre galectine-3 et maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent la galectine-3 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le diabète et l'inflammation chronique augmentent la galectine-3."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la galectine-3 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour des niveaux élevés."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de galectine-3 augmentent souvent avec l'âge."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des niveaux élevés de galectine-3."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec les maladies auto-immunes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies auto-immunes peuvent augmenter les niveaux de galectine-3."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/02/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Health Science, Ankara City Hospital, Ankara, Turkey.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Gazi University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Sungurlu State Hospital, Department of Psychiatry, Corum, Turkey.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
University of Health Sciences, Ankara City Hospital, Department of Psychiatry, Ankara, Turkey.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611.
Publications dans "Galectine -3" :
3 publications dans cette catégorie
Affiliations :
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611 ghudalla@bme.ufl.edu.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, University of Health Science, Ankara City Hospital, Ankara, Turkey. rabianazik@gmail.com.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Elazığ Psychiatric Hospital, Elazığ, Turkey.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA 32611. ghudalla@bme.ufl.edu.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Institute of Biostructures and Bioimaging, Consiglio Nazionale Delle Ricerche (CNR), 80134 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Institute of Biostructures and Bioimaging, Consiglio Nazionale Delle Ricerche (CNR), 80134 Naples, Italy.
Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.
Center for Life Sciences and Technologies (CESTEV), University of Naples Federico II, 80145 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Via Cinthia 4, 80126 Naples, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Institute of Crystallography, Consiglio Nazionale Delle Ricerche (CNR), 81100 Caserta, Italy.
Publications dans "Galectine -3" :
2 publications dans cette catégorie
Affiliations :
Institute of Biostructures and Bioimaging, Consiglio Nazionale Delle Ricerche (CNR), 80134 Naples, Italy.
Interuniversity Research Centre on Bioactive Peptides (CIRPEB), University of Naples Federico II, 80134 Naples, Italy.
Publications dans "Galectine -3" :
Systemic sclerosis is a systemic connective tissue disease whose main pathophysiological mechanism is a progressive fibrosis of internal organs and skin leading to thickening and induration. Blood ves...
Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc) with a mortality of 20% at 6 months. Once the leading cause of mortality in scleroderma (SSc), it remains ...
To describe systemic sclerosis (SSc) heart involvement in the ICU....
We retrospectively studied patients with previous diagnosis of SSc admitted to the ICU for acute cardiac dysfunction between 2012 and mid-2021....
9 female patients were included, mainly with diffuse SSc (n = 7, 78%). Six (67%) had digital ulcers. All but one patient complained about physical cardiac symptoms (n = 8, 89%), 5 (56%) had electrocar...
We report an uncommon and specific severe acute life-threatening cardiac dysfunction in SSc patients, which can be reversible but remains associated with a poor long-term prognosis, which can be rever...
Juvenile Scleroderma is a rare autoimmune disease of the connective tissue. Its concurrence with COVID-19 can lead to limb ischemia as both disease entities are pro-inflammatory and pro-thrombotic. To...
An adolescent with acute limb ischemia presented with a history of generalized hypo-and-hyperpigmented skin lesions and mild, non-productive cough. She tested positive for SARS-CoV-2 on nasopharyngeal...
There is evolving knowledge about the interplay of COVID-19 hyperinflammatory state and rheumatologic disorders. COVID-19 is thought to exacerbate cutaneous manifestations of autoimmune disorders via ...
Scleroderma renal crisis (SRC) is a rare and severe manifestation of systemic sclerosis (SSc). Although it is well documented that Black patients with SSc have worse morbidity and mortality than non-B...
Using the electronic health record of the US Military Health System, we conducted a comprehensive chart review of each patient with SSc from 2005 to 2016. The final study cohort was comprised of 31 SR...
Of 353 patients, 294 had identifiable race (79 Black, 215 non-Black). Thirteen of 79 Black patients (16.5%) versus 16 of 215 (7.4%) non-Black patients developed SRC (P = 0.02). On adjusted analysis, B...
Black race was independently associated with a higher risk of future SRC. Further studies are needed to elucidate the mechanisms that underlie this important association....
Scleroderma is a rare complication in taxanes therapy. Although individual cases of taxanes-induced scleroderma have been reported, the clinical manifestation and treatment outcomes were reviewed and ...
A PubMed literature review on published cases of taxanes-induced scleroderma up until April 2022 was included for analysis....
The search identified 27 patients with adequate information for analysis. Of the 28 patients, including the one presented here, 22 were female. Peripheral edema was the most common symptom in all but ...
Taxanes-induced scleroderma is different from idiopathic scleroderma. Physicians should be aware of this condition in order to provide early diagnosis and apply appropriate management in order to avoi...
Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare pediatric conditions often associated with severe morbidities. Delays in diagnosis are common, increasing the risk for permane...
In this cross-sectional study, caregivers of juvenile LS or SSc patients were recruited from a virtual family scleroderma educational conference and a juvenile scleroderma online interest group. The s...
The response rate was 61% (73/120), with 38 parents of LS patients and 31 parents of SSc patients. Most patients were female (80%) and over half were non-Hispanic white (55%). Most families had at lea...
Caregivers of children with LS or SSc reported numerous common barriers to the diagnosis, treatment, and ongoing care of juvenile scleroderma. The major problem highlighted was the lack of knowledge o...
The purpose of this study was to assess the skin involvement in systemic scleroderma patients (SSc) with 2D-Shear Wave Elastography (2D-SWE) and to review the corelation between skin elasticity and pu...
Thirty SSc patients and 30 controls were examined using 2D-SWE. The demographics matched both groups. B-mode ultrasound (US) and 2D-SWE assessed skin thickness and elastography from the ventral side o...
US parameter values (skin thickness, median kPa, median m/s) were higher in the SSc patient group (1.78 ± 0.36 mm, 22.15 ± 16.26, 2.60 ± 0.82, respectively) compared to the control group (1.55 ± 0.2 m...
2D-SWE is a promising non-invasive method to evaluate skin involvement in SSc patient group. For pulmonary involvement we need more data with bigger patient groups....
The spectrum of kidney involvement in systemic sclerosis (SSc) includes scleroderma renal crisis, widely recognized as the most severe renal-vascular complication, but also several forms of chronic re...
Systemic sclerosis is a complex multisystem connective tissue disease resulting in fibrosis of the skin and internal organs. Exposure to corticosteroids can trigger scleroderma renal crisis, a life-th...